Journal Mobile Options
Table of Contents
Vol. 25, No. 6, 2008
Issue release date: July 2008
Dement Geriatr Cogn Disord 2008;25:516–523
(DOI:10.1159/000129696)

CSF/Serum Folate Gradient: Physiology and Determinants with Special Reference to Dementia

Hagnelius N.-O. · Wahlund L.-O. · Nilsson T.K.
aDepartment of Geriatrics, and bDepartment of Clinical Chemistry, Örebro University Hospital, Örebro, and cDepartment of Clinical Neuroscience, Neurotec, Division of Geriatric Medicine, Neurotec, Karolinska Institutet, Stockholm, Sweden

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: Folate depletion has been implicated as a risk factor for neurodegenerative disorders. We hypothesized that transport of folate to the cerebrospinal fluid (CSF) compartment could be involved in the pathophysiology of these disorders. Methods: The CSF/serum folate gradient (RCSF/S) was studied in 205 subjects with suspected cognitive disorder. Its relation to clinical and biochemical indices, including the integrity of the blood-CSF barrier, were characterized. Results: In subjects who were diagnosed as nondemented (ND) the mean RCSF/S ± SD was 2.46 ± 0.62 versus 2.09 ± 0.67 (p = 0.008) in the dementia subgroup with a vascular component (VaD + mixed). The ND subgroup had higher CSF folate (p = 0.001) and lower serum homocysteine values (p = 0.001) than the VaD + mixed subgroup. The folate gradient RCSF/S was negatively correlated with serum folate (p < 0.001, R2 = 0.518) and to the albumin ratio, a blood-CSF barrier biomarker (β = –0.235). The Alzheimer patients had RCSF/S and albumin ratios similar to the ND subjects. Conclusion: The RCSF/S was significantly lower in the VaD + mixed dementia subgroup, suggestive of a defect in the transport of folate over the choroid plexus that seems to be characteristic of, and limited to, the VaD + mixed dementia subgroup.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Russell JSR, Batten FE, Collier J: Subacute combined degeneration of the spinal cord. Brain 1900;23:39–110.

    External Resources

  2. Strachan RW, Henderson JG: Psychiatric syndromes due to avitaminosis B 12 with normal blood and marrow. Q J Med 1965;34:303–317.
  3. Regland B, Abrahamsson L, Blennow K, Gottfries CG, Wallin A: Vitamin B12 in CSF: reduced CSF/serum B12 ratio in demented men. Acta Neurol Scand 1992;85:276–281.
  4. Grant HC, Hoffbrand AV, Wells DG: Folate deficiency and neurological disease. Lancet 1965;2:763–767.
  5. Parry TE: Folate responsive neuropathy. Presse Med 1994;23:131–137.
  6. Corrada MM, Kawas C, Hallfrisch J, Muller D, Brookmeyer R: Reduced risk of Alzheimer’s disease with high folate intake: the Baltimore longitudinal study of aging. Alzheimers Demen 2005;1:11–18.
  7. Bazzano LA, He J, Ogden LG, Loria C, Vupputuri S, Myers L, Whelton PK: Dietary intake of folate and risk of stroke in US men and women: NHANES I epidemiologic follow-up study – National Health and Nutrition Examination Survey. Stroke 2002;33:1183–1188.
  8. Doshi SN, McDowell IF, Moat SJ, Payne N, Durrant HJ, Lewis MJ, Goodfellow J: Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 2002;105:22–26.
  9. MRC Vitamin Study Research Group: Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338:131–137.
  10. Bottiglieri T, Laundy M, Crellin R, Toone BK, Carney MW, Reynolds EH: Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 2000;69:228–232.
  11. De Lau LM, Refsum H, Smith AD, Johnston C, Breteler MM: Plasma folate concentration and cognitive performance: Rotterdam Scan Study. Am J Clin Nutr 2007;86:728–734.
  12. D’Anci KE, Rosenberg IH: Folate and brain function in the elderly. Curr Opin Clin Nutr Metab Care 2004;7:659–664.
  13. Snowdon DA, Tully CL, Smith CD, Riley KP, Markesbery WR: Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun study. Am J Clin Nutr 2000;71:993–998.
  14. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino RB, Wilson PW, Wolf PA: Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 2002;346:476–483.
  15. Geller J, Kronn D, Jayabose S, Sandoval C: Hereditary folate malabsorption: family report and review of the literature. Medicine (Baltimore) 2002;81:51–68.
  16. Ramaekers VT, Blau N: Cerebral folate deficiency. Dev Med Child Neurol 2004;46:843–851.
  17. Balk E, Chung M, Raman G, Tatsioni A, Chew P, Ip S, DeVine D, Lau J: B vitamins and berries and age-related neurodegenerative disorders. Evid Rep Technol Assess 2006;134:1–161.
  18. Tallaksen CM, Bohmer T, Bell H: Concentrations of the water-soluble vitamins thiamin, ascorbic acid, and folic acid in serum and cerebrospinal fluid of healthy individuals. Am J Clin Nutr 1992;56:559–564.
  19. Spector R: Micronutrient homeostasis in mammalian brain and cerebrospinal fluid. J Neurochem 1989;53:1667–1674.
  20. Reynolds EH, Gallagher BB, Mattson RH, Bowers M, Johnson AL: Relationship between serum and cerebrospinal fluid folate. Nature 1972;240:155–157.
  21. Herbert V, Zalusky R: Selective concentration of folic acid activity in cerebrospinal fluid. Fed Proc 1961;20:453.
  22. Shaw DM, Macsweeney DA, Johnson AL, O’Keeffe R, Naidoo D, Macleod DM, Jog S, Preece JM, Crowley JM: Folate and amine metabolites in senile dementia: a combined trial and biochemical study. Psychol Med 1971;1:166–171.
  23. Botez MI, Bachevalier J: The blood-brain barrier and folate deficiency. Am J Clin Nutr 1981;34:1725–1730.
  24. Serot JM, Christmann D, Dubost T, Bene MC, Faure GC: CSF-folate levels are decreased in late-onset AD patients. J Neural Transm 2001;108:93–99.
  25. Davson H, Segal MB: Physiology of the CSF and Blood-Brain Barriers. New York, CRC Press, 1996.
  26. Hagnelius N-O, Wahlund LO, Nilsson T: P2:28 CSF/serum folate ratio in dementia and non-dementia (abstract). Int Psychogeriatr 2005;17(suppl 2):270–271.
  27. Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  28. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), ed 4. Washington, American Psychiatric Association, 1994.
  29. World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelindes. Geneva, World Health Organization, 1992.
  30. Langa KM, Foster NL, Larson EB: Mixed dementia: emerging concepts and therapeutic implications. JAMA 2004;292:2901–2908.
  31. Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, Russell RW, Symon L: Cerebral blood flow in dementia. Arch Neurol 1975;32:632–637.
  32. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–944.
  33. Wolters M, Hermann S, Hahn A: Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years. Eur J Nutr 2005;44:183–192.
  34. Blennow K, Hampel H: CSF markers for incipient Alzheimer’s disease. Lancet Neurol 2003;2:605–613.
  35. Tibbling G, Link H, Ohman S: Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 1977;37:385–390.
  36. Blennow K, Fredman P, Wallin A, Gottfries CG, Karlsson I, Langstrom G, Skoog I, Svennerholm L, Wikkelso C: Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18–88 years of age. Eur Neurol 1993;33:129–133.
  37. Willems HP, Bos GM, Gerrits WB, den Heijer M, Vloet S, Blom HJ: Acidic citrate stabilizes blood samples for assay of total homocysteine. Clin Chem 1998;44:342–345.
  38. Alperin JB, Haggard ME: Cerebrospinal fluid folate (CFA) and the blood brain barrier. Clin Res 1970;18:40.
  39. Spector R: Identification of folate binding macromolecule in rabbit choroid plexus. J Biol Chem 1977;252:3364–3370.
  40. Bottiglieri T, Reynolds EH, Laundy M: Folate in CSF and age (letter). J Neurol Neurosurg Psychiatry 2000;69:562.
  41. Obeid R, Kostopoulos P, Knapp JP, Kasoha M, Becker G, Fassbender K, Herrmann W: Biomarkers of folate and vitamin B12 are related in blood and cerebrospinal fluid. Clin Chem 2007;53:326–333.
  42. Jensen ON, Olesen OV: Folic acid concentrations in cerebrospinal fluid in relation to anticonvulsant drugs and cerebral atrophy. Acta Psychiatr Scand 1971;47:206–212.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50